These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32215869)

  • 1. The Biology of Immune-Active Cancers and Their Regulatory Mechanisms.
    Bedognetti D; Cesano A; Marincola FM; Wang E
    Cancer Treat Res; 2020; 180():149-172. PubMed ID: 32215869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of eIF2alpha phosphorylation during immunogenic cell death.
    Bezu L; Wu Chuang A; Humeau J; Kroemer G; Kepp O
    Methods Enzymol; 2019; 629():53-69. PubMed ID: 31727256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.
    Aaes TL; Vandenabeele P
    Cell Death Differ; 2021 Mar; 28(3):843-860. PubMed ID: 33214663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells.
    Zwirner NW; Croci DO; Domaica CI; Rabinovich GA
    Curr Pharm Des; 2010 Jan; 16(3):255-67. PubMed ID: 20109135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic Cell Death-Based Cancer Vaccines.
    Jin MZ; Wang XP
    Front Immunol; 2021; 12():697964. PubMed ID: 34135914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.
    Radogna F; Diederich M
    Biochem Pharmacol; 2018 Jul; 153():12-23. PubMed ID: 29438676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment.
    Yamazaki T; Vanpouille-Box C; Demaria S; Galluzzi L
    Cancer Treat Res; 2020; 180():281-296. PubMed ID: 32215874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of immunogenic cell death elicited by radiation therapy.
    Galassi C; Klapp V; Yamazaki T; Galluzzi L
    Immunol Rev; 2024 Jan; 321(1):20-32. PubMed ID: 37679959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
    Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
    Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice.
    Zhang J; Pan S; Jian C; Hao L; Dong J; Sun Q; Jin H; Han X
    Front Immunol; 2021; 12():819405. PubMed ID: 35069604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alarmins and immunity.
    Yang D; Han Z; Oppenheim JJ
    Immunol Rev; 2017 Nov; 280(1):41-56. PubMed ID: 29027222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural modulators of the hallmarks of immunogenic cell death.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic PANoptosis-Initiated Cancer Sono-Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle.
    Zhou L; Lyu J; Liu F; Su Y; Feng L; Zhang X
    Adv Mater; 2024 Jan; 36(2):e2305361. PubMed ID: 37699593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural compound inducers of immunogenic cell death.
    Diederich M
    Arch Pharm Res; 2019 Jul; 42(7):629-645. PubMed ID: 30955159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
    Kochin V; Nishikawa H
    Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Immune Resistance: How Cancer Protects from Immune Attack.
    Ribas A
    Cancer Discov; 2015 Sep; 5(9):915-9. PubMed ID: 26272491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases.
    Grazioli S; Pugin J
    Front Immunol; 2018; 9():832. PubMed ID: 29780380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.